Biofrontera AG
Ansprechpartner: Investor Relations
Tel.: +49 (0) 214 87 63 20


Public disclosure of inside information according to article 17 MAR

Biofrontera AG: Biofrontera AG reports result of the capital increase resolved on April 07, 2022

Leverkusen, Germany (pta024/11.11.2022/18:10) - The shareholders' meeting of Biofrontera AG on April 07, 2022 resolved to increase the share capital of the Company by up to EUR 7,089,673 by issuing up to 7,089,673 new registered no-par value shares with a notional interest in the share capital of EUR 1.00 each ("New Shares") against cash contributions.

According to today's results, a total of 7,089,673 new shares were placed at a subscription price of EUR 1.00 each. Subscription rights were exercised for at least 6.9 million New Shares. The offer has been oversubscribed.

The gross proceeds therefore amount to EUR 7,089,673. The execution of the capital increase will be filed for registration in the Commercial Register shortly.

The funds from the capital increase should enable the Company to advance its strategic business development and market penetration as fast as possible.

Emitter: Biofrontera AG
Hemmelrather Weg 201
51377 Leverkusen
Contact Person: Investor Relations
Phone: +49 (0) 214 87 63 20
Stock Exchanges: regulated market in Dusseldorf, Frankfurt; free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate
ISIN(s): DE0006046113 (share)
Other Stock Exchanges: US OTC
98.795 Abonnenten
204.737 Meldungen
84.658 Pressefotos


29.11.2022 - 14:05 | Financial Planning Standards Board Deutschland e.V.
29.11.2022 - 13:55 | pressetext.redaktion
29.11.2022 - 11:30 | Pressestelle Salzburg Wohnbau c/o JAGER PR
29.11.2022 - 11:30 | FRISCHBLUT Markenführung und Kommunikations GmbH
29.11.2022 - 11:30 | pressetext.redaktion